Literature DB >> 33599805

[Why are too few patients with colorectal liver metastases submitted to resection?]

G A Stavrou1,2, O Ghamarnejad3, Karl J Oldhafer4,5.   

Abstract

The resection of colorectal liver metastases (CRLM) within the framework of a multimodal treatment concept is a generally accepted and potentially curative treatment approach. Despite the fact that liver surgery represents a survival extension for patients with a good quality of life, this treatment option is offered to nowhere near all patients. This article summarizes the results of liver resection for CRLM patients and discusses the reasons for the different estimations of resectability even by experienced liver surgeons. The complexity of the treatment is exemplarily shown based on a case report.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Case numbers; Metastases; Resectability; Resection rate; Survival benefit

Mesh:

Year:  2021        PMID: 33599805     DOI: 10.1007/s00104-021-01363-3

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  24 in total

Review 1.  [Preconditioning of the liver].

Authors:  I Capobianco; J Strohäker; A Della Penna; S Nadalin; A Königsrainer
Journal:  Chirurg       Date:  2019-07       Impact factor: 0.955

2.  High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.

Authors:  Antoine Brouquet; Eddie K Abdalla; Scott Kopetz; Christopher R Garrett; Michael J Overman; Cathy Eng; Andreas Andreou; Evelyne M Loyer; David C Madoff; Steven A Curley; Jean-Nicolas Vauthey
Journal:  J Clin Oncol       Date:  2011-01-24       Impact factor: 44.544

3.  Extended liver venous deprivation before major hepatectomy induces marked and very rapid increase in future liver remnant function.

Authors:  Boris Guiu; François Quenet; Laure Escal; Frédéric Bibeau; Lauranne Piron; Philippe Rouanet; Jean-Michel Fabre; Eric Jacquet; Alban Denys; Pierre-Olivier Kotzki; Daniel Verzilli; Emmanuel Deshayes
Journal:  Eur Radiol       Date:  2017-01-18       Impact factor: 5.315

4.  Improved survival after resection of colorectal liver metastases in patients with unresectable lung metastases.

Authors:  Markus Albertsmeier; Kathrin Riedl; Anna-Janina Stephan; Moritz Drefs; Tobias S Schiergens; Jutta Engel; Martin K Angele; Jens Werner; Markus Guba
Journal:  HPB (Oxford)       Date:  2019-08-06       Impact factor: 3.647

5.  Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Authors:  R Adam; A Laurent; D Azoulay; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

6.  Mortality after liver surgery in Germany.

Authors:  N Filmann; D Walter; E Schadde; C Bruns; T Keck; H Lang; K Oldhafer; H J Schlitt; M R Schön; E Herrmann; W O Bechstein; A A Schnitzbauer
Journal:  Br J Surg       Date:  2019-07-24       Impact factor: 6.939

7.  Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates.

Authors:  G Folprecht; A Grothey; S Alberts; H-R Raab; C-H Köhne
Journal:  Ann Oncol       Date:  2005-05-03       Impact factor: 32.976

8.  Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

Authors:  Gunnar Folprecht; Thomas Gruenberger; Wolf O Bechstein; Hans-Rudolf Raab; Florian Lordick; Jörg T Hartmann; Hauke Lang; Andrea Frilling; Jan Stoehlmacher; Jürgen Weitz; Ralf Konopke; Christian Stroszczynski; Torsten Liersch; Detlev Ockert; Thomas Herrmann; Eray Goekkurt; Fabio Parisi; Claus-Henning Köhne
Journal:  Lancet Oncol       Date:  2009-11-26       Impact factor: 41.316

9.  Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?

Authors:  John M Creasy; Eran Sadot; Bas Groot Koerkamp; Joanne F Chou; Mithat Gonen; Nancy E Kemeny; Vinod P Balachandran; T Peter Kingham; Ronald P DeMatteo; Peter J Allen; Leslie H Blumgart; William R Jarnagin; Michael I D'Angelica
Journal:  Surgery       Date:  2018-02-15       Impact factor: 3.982

10.  Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma.

Authors:  Christina Hackl; Peter Neumann; Michael Gerken; Martin Loss; Monika Klinkhammer-Schalke; Hans J Schlitt
Journal:  BMC Cancer       Date:  2014-11-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.